Afentra, an upstream oil and gas company focused on acquiring production and development assets in Africa,has provided an operational and financial...
Vous n'êtes pas connecté
Maroc - ENERGY PEDIA.COM - 10/07/2024 14:44
Afentra, the upstream oil and gas company focused on acquiring production and development assets in Africa, has provided an update for the 6 months ending 30 June 2024. The Company completed the Azule Acquisition in May 2024 for a net consideration of $28.4 million and has been awarded the Kwanza onshore license KON 19, demonstrating its successful efforts to expand its business in Angola.
Afentra, an upstream oil and gas company focused on acquiring production and development assets in Africa,has provided an operational and financial...
Tullow Oil has issued a business and guidance update. In recent months Tullow has successfully completed the sale of its entire working interest in...
Equinor has awarded new framework agreements for insulation, scaffolding, and surface treatment (ISS) at its onshore plants in Norway. The […]
Equinor has awarded new framework agreements for insulation, scaffolding, and surface treatment (ISS) at its onshore plants in Norway. The […]
TotalEnergies has announced the signing of an agreement with Energetický a prumyslový holding, a.s. (EPH) for the acquisition of 50% of its flexible...
DNO, the Norwegian oil and gas operator, has announced the divestment of its 7.604 percent stake in the Ekofisk Previously Produced Fields (PPF)...
Harlay Avocats has advised the sellers and Cosmian Tech. The Atos Group has completed the acquisition of Cosmian Tech, a French deep tech company...
Cenovus Energy has announced that its acquisition of MEG Energy Corp. has been completed. This acquisition strengthens Cenovus’s portfolio of...
Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery...
Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery...